At a glance
- Originator Merck & Co
- Class Antiretrovirals
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 11 Oct 1994 No-Development-Reported for HIV infections treatment in USA (Unknown route)